These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 37682463)

  • 1. Comparison of In Vitro Corneal Permeation and In Vivo Ocular Bioavailability in Rabbits of Three Marketed Latanoprost Formulations.
    Chauchat L; Guerin C; Kaluzhny Y; Renard JP
    Eur J Drug Metab Pharmacokinet; 2023 Nov; 48(6):633-645. PubMed ID: 37682463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and in vivo comparative toxicological study of a new preservative-free latanoprost formulation.
    Pauly A; Roubeix C; Liang H; Brignole-Baudouin F; Baudouin C
    Invest Ophthalmol Vis Sci; 2012 Dec; 53(13):8172-80. PubMed ID: 23150620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative study of a preservative-free latanoprost cationic emulsion (Catioprost) and a BAK-preserved latanoprost solution in animal models.
    Daull P; Buggage R; Lambert G; Faure MO; Serle J; Wang RF; Garrigue JS
    J Ocul Pharmacol Ther; 2012 Oct; 28(5):515-23. PubMed ID: 22671995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 24-Hour Efficacy and Ocular Surface Health with Preservative-Free Tafluprost Alone and in Conjunction with Preservative-Free Dorzolamide/Timolol Fixed Combination in Open-Angle Glaucoma Patients Insufficiently Controlled with Preserved Latanoprost Monotherapy.
    Konstas AG; Boboridis KG; Kapis P; Marinopoulos K; Voudouragkaki IC; Panayiotou D; Mikropoulos DG; Pagkalidou E; Haidich AB; Katsanos A; Quaranta L
    Adv Ther; 2017 Jan; 34(1):221-235. PubMed ID: 27913991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conjunctival and corneal reactions in rabbits following short- and repeated exposure to preservative-free tafluprost, commercially available latanoprost and 0.02% benzalkonium chloride.
    Liang H; Baudouin C; Pauly A; Brignole-Baudouin F
    Br J Ophthalmol; 2008 Sep; 92(9):1275-82. PubMed ID: 18723745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of benzalkonium chloride in topical glaucoma treatment: An investigation of the efficacy and safety of benzalkonium chloride-preserved intraocular pressure-lowering eye drops and their effect on conjunctival goblet cells.
    Nagstrup AH
    Acta Ophthalmol; 2023 Dec; 101 Suppl 278():3-21. PubMed ID: 38037546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of corneal and conjunctival changes after dosing of travoprost preserved with sofZia, latanoprost with 0.02% benzalkonium chloride, and preservative-free artificial tears.
    Kahook MY; Noecker RJ
    Cornea; 2008 Apr; 27(3):339-43. PubMed ID: 18362664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparing the effect of benzalkonium chloride-preserved, polyquad-preserved, and preservative-free prostaglandin analogue eye drops on cultured human conjunctival goblet cells.
    Hedengran A; Freiberg J; May Hansen P; Boix-Lemonche G; Utheim TP; Dartt DA; Petrovski G; Heegaard S; Kolko M
    J Optom; 2024; 17(1):100481. PubMed ID: 37788596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preservative-free latanoprost eye drops in patients with primary open-angle glaucoma/ocular hypertension.
    Sanford M
    Clin Drug Investig; 2014 Jul; 34(7):521-8. PubMed ID: 24895141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cytotoxic effects of preserved and preservative-free prostaglandin analogs on human corneal and conjunctival epithelium in vitro and the distribution of benzalkonium chloride homologs in ocular surface tissues in vivo.
    Pellinen P; Huhtala A; Tolonen A; Lokkila J; Mäenpää J; Uusitalo H
    Curr Eye Res; 2012 Feb; 37(2):145-54. PubMed ID: 22049909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced in vivo ocular surface toxicity with polyquad-preserved travoprost versus benzalkonium-preserved travoprost or latanoprost ophthalmic solutions.
    Liang H; Brignole-Baudouin F; Riancho L; Baudouin C
    Ophthalmic Res; 2012; 48(2):89-101. PubMed ID: 22473057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative in vitro toxicology study of travoprost polyquad-preserved, travoprost BAK-preserved, and latanoprost BAK-preserved ophthalmic solutions on human conjunctival epithelial cells.
    Brignole-Baudouin F; Riancho L; Liang H; Baudouin C
    Curr Eye Res; 2011 Nov; 36(11):979-88. PubMed ID: 21999224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Latanoprost Antiglaucoma Eyedrops and Their Excipients on Toxicity and Healing Characteristics in the Ex Vivo Eye Irritation Test System.
    Panfil C; Chauchat L; Guerin C; Rebika H; Sahyoun M; Schrage N
    Ophthalmol Ther; 2023 Oct; 12(5):2641-2655. PubMed ID: 37486574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic and Ocular Toxicity Evaluation of Latanoprost Ophthalmic Solution, 0.005%, with Preservative Level Reduced to Below the Limit of Quantitation.
    Venkatesh S; Richardson M
    J Ocul Pharmacol Ther; 2023 Nov; 39(9):622-630. PubMed ID: 37582270
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of benzalkonium chloride-preserved, polyquad-preserved, and sofZia-preserved topical glaucoma medications on human ocular epithelial cells.
    Ammar DA; Noecker RJ; Kahook MY
    Adv Ther; 2010 Nov; 27(11):837-45. PubMed ID: 20931366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of corneal epithelial integrity after acute exposure to ocular hypotensive agents preserved with and without benzalkonium chloride.
    Whitson JT; Cavanagh HD; Lakshman N; Petroll WM
    Adv Ther; 2006; 23(5):663-71. PubMed ID: 17142200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corneal epithelial cell viability following exposure to ophthalmic solutions containing preservatives and/or antihypertensive agents.
    Whitson JT; Petroll WM
    Adv Ther; 2012 Oct; 29(10):874-88. PubMed ID: 23065664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of benzalkonium chloride- or polyquad-preserved fixed combination glaucoma medications on human trabecular meshwork cells.
    Ammar DA; Kahook MY
    Mol Vis; 2011; 17():1806-13. PubMed ID: 21750606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro comparative toxicology of polyquad-preserved and benzalkonium chloride-preserved travoprost/timolol fixed combination and latanoprost/timolol fixed combination.
    Brignole-Baudouin F; Riancho L; Liang H; Nakib Z; Baudouin C
    J Ocul Pharmacol Ther; 2011 Jun; 27(3):273-80. PubMed ID: 21410334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of ophthalmic solution preservatives: a comparison of latanoprost with 0.02% benzalkonium chloride and travoprost with the sofZia preservative system.
    Ryan G; Fain JM; Lovelace C; Gelotte KM
    BMC Ophthalmol; 2011 Apr; 11():8. PubMed ID: 21510881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.